Anxiety Disorders Completed Phase 2 Trials for Lamotrigine (DB00555)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001482New Drugs in the Treatment of Mood DisordersTreatment